Improved cardiac function after prolonged hypothermic ischemia with the Na+/H+ exchange inhibitor HOE 694

M L Myers1, M Karmazyn

  • 1Department of Cardiovascular Surgery, University of Western Ontario, London, Canada.

Insights

Inhibiting sodium-hydrogen exchanger (Na+/H+) with HOE 694 significantly protects rabbit hearts from damage after 12-hour hypothermic storage. This finding suggests antiport inhibitors are effective for myocardial preservation.

Area of Science:

  • Cardiology
  • Cell Physiology
  • Biochemistry

Background:

  • Na+/H+ exchange is crucial for cardiac pH regulation.
  • This exchange mechanism can paradoxically cause tissue damage in reperfused myocardium.
  • Investigated the protective potential of a selective Na+/H+ exchange inhibitor, HOE 694.

Purpose of the Study:

  • To evaluate the efficacy of HOE 694 in preventing myocardial damage after prolonged hypothermic storage.
  • To determine the optimal timing for HOE 694 administration (cardioplegia vs. reperfusion).

Main Methods:

  • Isolated rabbit hearts underwent 12-hour hypothermic (4°C) ischemic arrest followed by 60-minute reperfusion (37°C).
  • HOE 694 was administered during cardioplegia and/or reperfusion.
  • Left ventricular function, creatine kinase release, and high-energy phosphate content were assessed.

Main Results:

  • HOE 694 treatment significantly improved systolic function recovery (approx. 80% vs. <40%) and reduced left ventricular end-diastolic pressure elevation.
  • Administration during reperfusion was more effective than during cardioplegia alone.
  • HOE 694 did not significantly alter tissue metabolite levels or creatine kinase release, except when added at reperfusion.

Conclusions:

  • HOE 694 demonstrates a marked protective effect against myocardial injury following extended hypothermic ischemia.
  • Na+/H+ exchange inhibitors show promise as a therapeutic strategy for myocardial preservation.
Abstract

Related Concept Videos